Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 895-896, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blázovics, A.
Right arrow Articles by Fehér, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blázovics, A.
Right arrow Articles by Fehér, J.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:895-896.)
© 1999 American Association for Clinical Chemistry, Inc.

Technical Briefs

Antioxidant Defense in Erythrocytes and Plasma of Patients with Active and Quiescent Crohn Disease and Ulcerative Colitis: A Chemiluminescent Study

Anna Blázovics1,a, Ágota Kovács, Andrea Lugasi2, Krisztina Hagymási1, Lajos Bíró2 and János Fehér1

1 Second2 Elizabeth County Hospital, Alsó erdõsor St. 7, Budapest H-1074, Hungary;
2 National Institute of Food-Hygiene and Nutrition, Gyáli Road 3/a, Budapest H-1097, Hungary;
a author for correspondence: e-mail Blaz@bel2.SOTE.hu

Inflammatory bowel disease (IBD) can be considered multifactorial in genetic background and with regard to neuro-endocrine regulation of immune reactivity to antigens of alimentary and bacterial origin (1). The roles of free radicals and the antioxidant defense mechanisms of the intestine are also well documented (2)(3). Aminosalicylates such as 5-aminosalicylic acid (5-ASA), when used in therapy, exhibit superoxide and hydroxyl-radical scavenger properties (4). This medication can partially restore the depleted mucosal antioxidant protective function that develops in IBD.

We used a simple luminol-dependent chemiluminescence method to study the antioxidant protective mechanisms in patients with IBD. Luminol-dependent chemiluminescence, as an indicator of a free radicals, is suitable for detection of the antioxidant status of tissue. The H2O2/·OH-microperoxidase-luminol system can be used to measure the total scavenger capacity (TSC) of the plasma and erythrocytes. We also determined the H+-donor activity and reducing power in the plasma.

1,1-Diphenyl-2-picryl-hydrazyl, stable radical; 5,5'-dithiobis-2-nitrobenzoic acid; luminol; and microperoxidase were obtained from Sigma. All other reagents were purchased from Reanal.

Twenty-six Caucasian volunteers (10 males, ages 26.6 ± 11.3 years; 16 females, ages 34.2 ± 13.6 years) served as a control group. Patients were divided into three groups—inactive, moderate, and severe—based on the severity of their disease according to the Crohn disease activity index (CDAI) and the ulcerative colitis (UC) activity index. Routine laboratory data and numerical values for pain, stool characteristics, well-being, and other factors were used to calculate the CDAI and the UC activity index (5). The UC activity index classifications for 22 patients were as follows: inactive, 1 male, . . . [Full Text of this Article]


Acknowledgments


Footnotes


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.